Global Psychiatric and Nervous Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Psychiatric and Nervous Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Psychiatric and Nervous Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Psychiatric and Nervous Drugs by Country/Region, 2017, 2022 & 2028

2.2 Psychiatric and Nervous Drugs Segment by Type

2.2.1 Antidepressants

2.2.2 Anti-anxiety

2.2.3 Antipsychotic

2.2.4 Mood Stabilizing

2.2.5 Stimulant Medications

2.2.6 Others

2.3 Psychiatric and Nervous Drugs Sales by Type

2.3.1 Global Psychiatric and Nervous Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Psychiatric and Nervous Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Psychiatric and Nervous Drugs Sale Price by Type (2017-2022)

2.4 Psychiatric and Nervous Drugs Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Psychiatric and Nervous Drugs Sales by Application

2.5.1 Global Psychiatric and Nervous Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Psychiatric and Nervous Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Psychiatric and Nervous Drugs Sale Price by Application (2017-2022)

3 Global Psychiatric and Nervous Drugs by Company

3.1 Global Psychiatric and Nervous Drugs Breakdown Data by Company

3.1.1 Global Psychiatric and Nervous Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Psychiatric and Nervous Drugs Sales Market Share by Company (2020-2022)

3.2 Global Psychiatric and Nervous Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Psychiatric and Nervous Drugs Revenue by Company (2020-2022)

3.2.2 Global Psychiatric and Nervous Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Psychiatric and Nervous Drugs Sale Price by Company

3.4 Key Manufacturers Psychiatric and Nervous Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Psychiatric and Nervous Drugs Product Location Distribution

3.4.2 Players Psychiatric and Nervous Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Psychiatric and Nervous Drugs by Geographic Region

4.1 World Historic Psychiatric and Nervous Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Psychiatric and Nervous Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Psychiatric and Nervous Drugs Annual Revenue by Geographic Region

4.2 World Historic Psychiatric and Nervous Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Psychiatric and Nervous Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Psychiatric and Nervous Drugs Annual Revenue by Country/Region

4.3 Americas Psychiatric and Nervous Drugs Sales Growth

4.4 APAC Psychiatric and Nervous Drugs Sales Growth

4.5 Europe Psychiatric and Nervous Drugs Sales Growth

4.6 Middle East & Africa Psychiatric and Nervous Drugs Sales Growth

5 Americas

5.1 Americas Psychiatric and Nervous Drugs Sales by Country

5.1.1 Americas Psychiatric and Nervous Drugs Sales by Country (2017-2022)

5.1.2 Americas Psychiatric and Nervous Drugs Revenue by Country (2017-2022)

5.2 Americas Psychiatric and Nervous Drugs Sales by Type

5.3 Americas Psychiatric and Nervous Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Psychiatric and Nervous Drugs Sales by Region

6.1.1 APAC Psychiatric and Nervous Drugs Sales by Region (2017-2022)

6.1.2 APAC Psychiatric and Nervous Drugs Revenue by Region (2017-2022)

6.2 APAC Psychiatric and Nervous Drugs Sales by Type

6.3 APAC Psychiatric and Nervous Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Psychiatric and Nervous Drugs by Country

7.1.1 Europe Psychiatric and Nervous Drugs Sales by Country (2017-2022)

7.1.2 Europe Psychiatric and Nervous Drugs Revenue by Country (2017-2022)

7.2 Europe Psychiatric and Nervous Drugs Sales by Type

7.3 Europe Psychiatric and Nervous Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Psychiatric and Nervous Drugs by Country

8.1.1 Middle East & Africa Psychiatric and Nervous Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Psychiatric and Nervous Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Psychiatric and Nervous Drugs Sales by Type

8.3 Middle East & Africa Psychiatric and Nervous Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Psychiatric and Nervous Drugs

10.3 Manufacturing Process Analysis of Psychiatric and Nervous Drugs

10.4 Industry Chain Structure of Psychiatric and Nervous Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Psychiatric and Nervous Drugs Distributors

11.3 Psychiatric and Nervous Drugs Customer

12 World Forecast Review for Psychiatric and Nervous Drugs by Geographic Region

12.1 Global Psychiatric and Nervous Drugs Market Size Forecast by Region

12.1.1 Global Psychiatric and Nervous Drugs Forecast by Region (2023-2028)

12.1.2 Global Psychiatric and Nervous Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Psychiatric and Nervous Drugs Forecast by Type

12.7 Global Psychiatric and Nervous Drugs Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Psychiatric and Nervous Drugs Product Offered

13.1.3 Pfizer Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Ely Lilly

13.2.1 Ely Lilly Company Information

13.2.2 Ely Lilly Psychiatric and Nervous Drugs Product Offered

13.2.3 Ely Lilly Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Ely Lilly Main Business Overview

13.2.5 Ely Lilly Latest Developments

13.3 Actavis

13.3.1 Actavis Company Information

13.3.2 Actavis Psychiatric and Nervous Drugs Product Offered

13.3.3 Actavis Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Actavis Main Business Overview

13.3.5 Actavis Latest Developments

13.4 Mylan

13.4.1 Mylan Company Information

13.4.2 Mylan Psychiatric and Nervous Drugs Product Offered

13.4.3 Mylan Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Mylan Main Business Overview

13.4.5 Mylan Latest Developments

13.5 Randox

13.5.1 Randox Company Information

13.5.2 Randox Psychiatric and Nervous Drugs Product Offered

13.5.3 Randox Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Randox Main Business Overview

13.5.5 Randox Latest Developments

13.6 Intellipharmaceutics

13.6.1 Intellipharmaceutics Company Information

13.6.2 Intellipharmaceutics Psychiatric and Nervous Drugs Product Offered

13.6.3 Intellipharmaceutics Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Intellipharmaceutics Main Business Overview

13.6.5 Intellipharmaceutics Latest Developments

13.7 Astrazeneca

13.7.1 Astrazeneca Company Information

13.7.2 Astrazeneca Psychiatric and Nervous Drugs Product Offered

13.7.3 Astrazeneca Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Astrazeneca Main Business Overview

13.7.5 Astrazeneca Latest Developments

13.8 Lundbeck

13.8.1 Lundbeck Company Information

13.8.2 Lundbeck Psychiatric and Nervous Drugs Product Offered

13.8.3 Lundbeck Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Lundbeck Main Business Overview

13.8.5 Lundbeck Latest Developments

13.9 Allergan

13.9.1 Allergan Company Information

13.9.2 Allergan Psychiatric and Nervous Drugs Product Offered

13.9.3 Allergan Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Allergan Main Business Overview

13.9.5 Allergan Latest Developments

13.10 GSK

13.10.1 GSK Company Information

13.10.2 GSK Psychiatric and Nervous Drugs Product Offered

13.10.3 GSK Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 GSK Main Business Overview

13.10.5 GSK Latest Developments

13.11 Otsuka Pharmaceutical

13.11.1 Otsuka Pharmaceutical Company Information

13.11.2 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Product Offered

13.11.3 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Otsuka Pharmaceutical Main Business Overview

13.11.5 Otsuka Pharmaceutical Latest Developments

13.12 Takeda

13.12.1 Takeda Company Information

13.12.2 Takeda Psychiatric and Nervous Drugs Product Offered

13.12.3 Takeda Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Takeda Main Business Overview

13.12.5 Takeda Latest Developments

13.13 NHU Group

13.13.1 NHU Group Company Information

13.13.2 NHU Group Psychiatric and Nervous Drugs Product Offered

13.13.3 NHU Group Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 NHU Group Main Business Overview

13.13.5 NHU Group Latest Developments

13.14 Shionogi

13.14.1 Shionogi Company Information

13.14.2 Shionogi Psychiatric and Nervous Drugs Product Offered

13.14.3 Shionogi Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Shionogi Main Business Overview

13.14.5 Shionogi Latest Developments

13.15 APOTEX

13.15.1 APOTEX Company Information

13.15.2 APOTEX Psychiatric and Nervous Drugs Product Offered

13.15.3 APOTEX Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 APOTEX Main Business Overview

13.15.5 APOTEX Latest Developments

13.16 Chengdu Kanghong Pharmaceutical

13.16.1 Chengdu Kanghong Pharmaceutical Company Information

13.16.2 Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Product Offered

13.16.3 Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Chengdu Kanghong Pharmaceutical Main Business Overview

13.16.5 Chengdu Kanghong Pharmaceutical Latest Developments

13.17 HUAHAI

13.17.1 HUAHAI Company Information

13.17.2 HUAHAI Psychiatric and Nervous Drugs Product Offered

13.17.3 HUAHAI Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 HUAHAI Main Business Overview

13.17.5 HUAHAI Latest Developments

13.18 Zhejiang Jianfeng

13.18.1 Zhejiang Jianfeng Company Information

13.18.2 Zhejiang Jianfeng Psychiatric and Nervous Drugs Product Offered

13.18.3 Zhejiang Jianfeng Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Zhejiang Jianfeng Main Business Overview

13.18.5 Zhejiang Jianfeng Latest Developments

13.19 Beijing Winsunny Pharmaceutical

13.19.1 Beijing Winsunny Pharmaceutical Company Information

13.19.2 Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Product Offered

13.19.3 Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Beijing Winsunny Pharmaceutical Main Business Overview

13.19.5 Beijing Winsunny Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Psychiatric and Nervous Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Psychiatric and Nervous Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Antidepressants

Table 4. Major Players of Anti-anxiety

Table 5. Major Players of Antipsychotic

Table 6. Major Players of Mood Stabilizing

Table 7. Major Players of Stimulant Medications

Table 8. Major Players of Others

Table 9. Global Psychiatric and Nervous Drugs Sales by Type (2017-2022) & (K Units)

Table 10. Global Psychiatric and Nervous Drugs Sales Market Share by Type (2017-2022)

Table 11. Global Psychiatric and Nervous Drugs Revenue by Type (2017-2022) & ($ million)

Table 12. Global Psychiatric and Nervous Drugs Revenue Market Share by Type (2017-2022)

Table 13. Global Psychiatric and Nervous Drugs Sale Price by Type (2017-2022) & (US$/Unit)

Table 14. Global Psychiatric and Nervous Drugs Sales by Application (2017-2022) & (K Units)

Table 15. Global Psychiatric and Nervous Drugs Sales Market Share by Application (2017-2022)

Table 16. Global Psychiatric and Nervous Drugs Revenue by Application (2017-2022)

Table 17. Global Psychiatric and Nervous Drugs Revenue Market Share by Application (2017-2022)

Table 18. Global Psychiatric and Nervous Drugs Sale Price by Application (2017-2022) & (US$/Unit)

Table 19. Global Psychiatric and Nervous Drugs Sales by Company (2020-2022) & (K Units)

Table 20. Global Psychiatric and Nervous Drugs Sales Market Share by Company (2020-2022)

Table 21. Global Psychiatric and Nervous Drugs Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Psychiatric and Nervous Drugs Revenue Market Share by Company (2020-2022)

Table 23. Global Psychiatric and Nervous Drugs Sale Price by Company (2020-2022) & (US$/Unit)

Table 24. Key Manufacturers Psychiatric and Nervous Drugs Producing Area Distribution and Sales Area

Table 25. Players Psychiatric and Nervous Drugs Products Offered

Table 26. Psychiatric and Nervous Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Psychiatric and Nervous Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Psychiatric and Nervous Drugs Sales Market Share Geographic Region (2017-2022)

Table 31. Global Psychiatric and Nervous Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Psychiatric and Nervous Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Psychiatric and Nervous Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Psychiatric and Nervous Drugs Sales Market Share by Country/Region (2017-2022)

Table 35. Global Psychiatric and Nervous Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Psychiatric and Nervous Drugs Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Psychiatric and Nervous Drugs Sales by Country (2017-2022) & (K Units)

Table 38. Americas Psychiatric and Nervous Drugs Sales Market Share by Country (2017-2022)

Table 39. Americas Psychiatric and Nervous Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Psychiatric and Nervous Drugs Revenue Market Share by Country (2017-2022)

Table 41. Americas Psychiatric and Nervous Drugs Sales by Type (2017-2022) & (K Units)

Table 42. Americas Psychiatric and Nervous Drugs Sales Market Share by Type (2017-2022)

Table 43. Americas Psychiatric and Nervous Drugs Sales by Application (2017-2022) & (K Units)

Table 44. Americas Psychiatric and Nervous Drugs Sales Market Share by Application (2017-2022)

Table 45. APAC Psychiatric and Nervous Drugs Sales by Region (2017-2022) & (K Units)

Table 46. APAC Psychiatric and Nervous Drugs Sales Market Share by Region (2017-2022)

Table 47. APAC Psychiatric and Nervous Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Psychiatric and Nervous Drugs Revenue Market Share by Region (2017-2022)

Table 49. APAC Psychiatric and Nervous Drugs Sales by Type (2017-2022) & (K Units)

Table 50. APAC Psychiatric and Nervous Drugs Sales Market Share by Type (2017-2022)

Table 51. APAC Psychiatric and Nervous Drugs Sales by Application (2017-2022) & (K Units)

Table 52. APAC Psychiatric and Nervous Drugs Sales Market Share by Application (2017-2022)

Table 53. Europe Psychiatric and Nervous Drugs Sales by Country (2017-2022) & (K Units)

Table 54. Europe Psychiatric and Nervous Drugs Sales Market Share by Country (2017-2022)

Table 55. Europe Psychiatric and Nervous Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Psychiatric and Nervous Drugs Revenue Market Share by Country (2017-2022)

Table 57. Europe Psychiatric and Nervous Drugs Sales by Type (2017-2022) & (K Units)

Table 58. Europe Psychiatric and Nervous Drugs Sales Market Share by Type (2017-2022)

Table 59. Europe Psychiatric and Nervous Drugs Sales by Application (2017-2022) & (K Units)

Table 60. Europe Psychiatric and Nervous Drugs Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Psychiatric and Nervous Drugs Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Psychiatric and Nervous Drugs Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Psychiatric and Nervous Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Psychiatric and Nervous Drugs Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Psychiatric and Nervous Drugs Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Psychiatric and Nervous Drugs Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Psychiatric and Nervous Drugs Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Psychiatric and Nervous Drugs Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Psychiatric and Nervous Drugs

Table 70. Key Market Challenges & Risks of Psychiatric and Nervous Drugs

Table 71. Key Industry Trends of Psychiatric and Nervous Drugs

Table 72. Psychiatric and Nervous Drugs Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Psychiatric and Nervous Drugs Distributors List

Table 75. Psychiatric and Nervous Drugs Customer List

Table 76. Global Psychiatric and Nervous Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Psychiatric and Nervous Drugs Sales Market Forecast by Region

Table 78. Global Psychiatric and Nervous Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Psychiatric and Nervous Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Psychiatric and Nervous Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Psychiatric and Nervous Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Psychiatric and Nervous Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Psychiatric and Nervous Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Psychiatric and Nervous Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Psychiatric and Nervous Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Psychiatric and Nervous Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Psychiatric and Nervous Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Psychiatric and Nervous Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Psychiatric and Nervous Drugs Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Psychiatric and Nervous Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Psychiatric and Nervous Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Psychiatric and Nervous Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Psychiatric and Nervous Drugs Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Psychiatric and Nervous Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Psychiatric and Nervous Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 96. Pfizer Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 97. Pfizer Psychiatric and Nervous Drugs Product Offered

Table 98. Pfizer Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 99. Pfizer Main Business

Table 100. Pfizer Latest Developments

Table 101. Ely Lilly Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 102. Ely Lilly Psychiatric and Nervous Drugs Product Offered

Table 103. Ely Lilly Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 104. Ely Lilly Main Business

Table 105. Ely Lilly Latest Developments

Table 106. Actavis Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 107. Actavis Psychiatric and Nervous Drugs Product Offered

Table 108. Actavis Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 109. Actavis Main Business

Table 110. Actavis Latest Developments

Table 111. Mylan Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 112. Mylan Psychiatric and Nervous Drugs Product Offered

Table 113. Mylan Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 114. Mylan Main Business

Table 115. Mylan Latest Developments

Table 116. Randox Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 117. Randox Psychiatric and Nervous Drugs Product Offered

Table 118. Randox Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 119. Randox Main Business

Table 120. Randox Latest Developments

Table 121. Intellipharmaceutics Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 122. Intellipharmaceutics Psychiatric and Nervous Drugs Product Offered

Table 123. Intellipharmaceutics Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 124. Intellipharmaceutics Main Business

Table 125. Intellipharmaceutics Latest Developments

Table 126. Astrazeneca Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 127. Astrazeneca Psychiatric and Nervous Drugs Product Offered

Table 128. Astrazeneca Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 129. Astrazeneca Main Business

Table 130. Astrazeneca Latest Developments

Table 131. Lundbeck Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 132. Lundbeck Psychiatric and Nervous Drugs Product Offered

Table 133. Lundbeck Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 134. Lundbeck Main Business

Table 135. Lundbeck Latest Developments

Table 136. Allergan Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 137. Allergan Psychiatric and Nervous Drugs Product Offered

Table 138. Allergan Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 139. Allergan Main Business

Table 140. Allergan Latest Developments

Table 141. GSK Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 142. GSK Psychiatric and Nervous Drugs Product Offered

Table 143. GSK Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 144. GSK Main Business

Table 145. GSK Latest Developments

Table 146. Otsuka Pharmaceutical Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 147. Otsuka Pharmaceutical Psychiatric and Nervous Drugs Product Offered

Table 148. Otsuka Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 149. Otsuka Pharmaceutical Main Business

Table 150. Otsuka Pharmaceutical Latest Developments

Table 151. Takeda Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 152. Takeda Psychiatric and Nervous Drugs Product Offered

Table 153. Takeda Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 154. Takeda Main Business

Table 155. Takeda Latest Developments

Table 156. NHU Group Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 157. NHU Group Psychiatric and Nervous Drugs Product Offered

Table 158. NHU Group Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 159. NHU Group Main Business

Table 160. NHU Group Latest Developments

Table 161. Shionogi Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 162. Shionogi Psychiatric and Nervous Drugs Product Offered

Table 163. Shionogi Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 164. Shionogi Main Business

Table 165. Shionogi Latest Developments

Table 166. APOTEX Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 167. APOTEX Psychiatric and Nervous Drugs Product Offered

Table 168. APOTEX Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 169. APOTEX Main Business

Table 170. APOTEX Latest Developments

Table 171. Chengdu Kanghong Pharmaceutical Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 172. Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Product Offered

Table 173. Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 174. Chengdu Kanghong Pharmaceutical Main Business

Table 175. Chengdu Kanghong Pharmaceutical Latest Developments

Table 176. HUAHAI Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 177. HUAHAI Psychiatric and Nervous Drugs Product Offered

Table 178. HUAHAI Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 179. HUAHAI Main Business

Table 180. HUAHAI Latest Developments

Table 181. Zhejiang Jianfeng Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 182. Zhejiang Jianfeng Psychiatric and Nervous Drugs Product Offered

Table 183. Zhejiang Jianfeng Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 184. Zhejiang Jianfeng Main Business

Table 185. Zhejiang Jianfeng Latest Developments

Table 186. Beijing Winsunny Pharmaceutical Basic Information, Psychiatric and Nervous Drugs Manufacturing Base, Sales Area and Its Competitors

Table 187. Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Product Offered

Table 188. Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 189. Beijing Winsunny Pharmaceutical Main Business

Table 190. Beijing Winsunny Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Psychiatric and Nervous Drugs

Figure 2. Psychiatric and Nervous Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Psychiatric and Nervous Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Psychiatric and Nervous Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Psychiatric and Nervous Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Antidepressants

Figure 10. Product Picture of Anti-anxiety

Figure 11. Product Picture of Antipsychotic

Figure 12. Product Picture of Mood Stabilizing

Figure 13. Product Picture of Stimulant Medications

Figure 14. Product Picture of Others

Figure 15. Global Psychiatric and Nervous Drugs Sales Market Share by Type in 2021

Figure 16. Global Psychiatric and Nervous Drugs Revenue Market Share by Type (2017-2022)

Figure 17. Psychiatric and Nervous Drugs Consumed in Hospital Pharmacies

Figure 18. Global Psychiatric and Nervous Drugs Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 19. Psychiatric and Nervous Drugs Consumed in Retail Pharmacies

Figure 20. Global Psychiatric and Nervous Drugs Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 21. Psychiatric and Nervous Drugs Consumed in Online Pharmacies

Figure 22. Global Psychiatric and Nervous Drugs Market: Online Pharmacies (2017-2022) & (K Units)

Figure 23. Global Psychiatric and Nervous Drugs Sales Market Share by Application (2017-2022)

Figure 24. Global Psychiatric and Nervous Drugs Revenue Market Share by Application in 2021

Figure 25. Psychiatric and Nervous Drugs Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Psychiatric and Nervous Drugs Revenue Market Share by Company in 2021

Figure 27. Global Psychiatric and Nervous Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Psychiatric and Nervous Drugs Revenue Market Share by Geographic Region in 2021

Figure 29. Global Psychiatric and Nervous Drugs Sales Market Share by Region (2017-2022)

Figure 30. Global Psychiatric and Nervous Drugs Revenue Market Share by Country/Region in 2021

Figure 31. Americas Psychiatric and Nervous Drugs Sales 2017-2022 (K Units)

Figure 32. Americas Psychiatric and Nervous Drugs Revenue 2017-2022 ($ Millions)

Figure 33. APAC Psychiatric and Nervous Drugs Sales 2017-2022 (K Units)

Figure 34. APAC Psychiatric and Nervous Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Europe Psychiatric and Nervous Drugs Sales 2017-2022 (K Units)

Figure 36. Europe Psychiatric and Nervous Drugs Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Psychiatric and Nervous Drugs Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Psychiatric and Nervous Drugs Revenue 2017-2022 ($ Millions)

Figure 39. Americas Psychiatric and Nervous Drugs Sales Market Share by Country in 2021

Figure 40. Americas Psychiatric and Nervous Drugs Revenue Market Share by Country in 2021

Figure 41. United States Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Psychiatric and Nervous Drugs Sales Market Share by Region in 2021

Figure 46. APAC Psychiatric and Nervous Drugs Revenue Market Share by Regions in 2021

Figure 47. China Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Psychiatric and Nervous Drugs Sales Market Share by Country in 2021

Figure 54. Europe Psychiatric and Nervous Drugs Revenue Market Share by Country in 2021

Figure 55. Germany Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Psychiatric and Nervous Drugs Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Psychiatric and Nervous Drugs Revenue Market Share by Country in 2021

Figure 62. Egypt Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Psychiatric and Nervous Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Psychiatric and Nervous Drugs in 2021

Figure 68. Manufacturing Process Analysis of Psychiatric and Nervous Drugs

Figure 69. Industry Chain Structure of Psychiatric and Nervous Drugs

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles